title: Somatuline LA: a new treatment for acromegaly.
abstract: Somatostatin analogues have become well established as treatment for acromegaly. However, to ensure growth hormone (GH) levels are sufficiently suppressed, thrice daily subcutaneous injections are required. The introduction of Somatuline LA, a long acting formulation which controls plasma GH levels for up to 14 days and improves acromegaly symptoms, is likely to improve patient compliance and quality of life.
authors.affiliation: Centre for Neuroendocrinology, Royal Free, London.
authors.forename: P M
authors.initials: PM
authors.lastname: Bouloux
mesh_terms: D000172:Acromegaly / Q000188:drug therapy*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006801:Humans; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D003692:Delayed-Action Preparations; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin